Insights into 2D MXenes for Versatile Biomedical Applications: Current Advances and Challenges Ahead

Current research on ceramic-based biomaterials has focused on their use in hard tissue engineering due to their controllable biocompatibility and mechanical properties. These materials are typically produced through high-temperature solid-phase reactions, making them suitable for bone scaffolds. However, their potential in disease theranostics remains underexplored, largely because they lack the functional properties needed for vascular system interactions. This gap has motivated scientists to explore alternative materials with enhanced functionalities. 2D materials have gained attention for their unique properties that could address these limitations. Prior studies have demonstrated the versatility of 2D materials in various biomedical contexts. However, no prior work had resolved how these materials could be applied in theranostic and diagnostic roles. This paper introduces a new class of 2D materials that may offer solutions to these challenges.

This study aims to explore the biomedical potential of 2D MXenes, a novel class of ultrathin nanosheet materials derived from MAX phase ceramics. The researchers propose that MXenes could serve as versatile platforms for multiple biomedical applications. The specific problem addressed is the lack of functional materials that can operate within the vascular system and support theranostic applications. The motivation stems from the need to develop biocompatible nanosystems that can meet the stringent requirements of biomedical use. The authors suggest that MXenes may offer a solution due to their metallic conductivity and hydrophilic nature. This work reviews recent progress in MXene-based biomedical applications, focusing on design strategies and therapeutic modalities. The goal is to evaluate how MXenes can be engineered for clinical translation in nanomedicine.

The researchers conducted a comprehensive review of recent advancements in 2D MXene materials for biomedical applications. They analyzed the design and synthesis strategies used to create MXene nanosheets with specific physiochemical properties. The study included an evaluation of therapeutic approaches, such as drug delivery and antimicrobial activity, as well as diagnostic imaging and biosensing capabilities. The authors also examined biosafety concerns and the potential for clinical translation. Data were synthesized from peer-reviewed publications and experimental studies. The review approach focused on identifying key findings from the literature related to MXene functionality in biomedical contexts. The authors propose that the unique properties of MXenes make them suitable for a range of biomedical applications.

The study highlights the metallic conductivity and hydrophilic nature of MXenes as key properties that may enable their use in biomedical applications. It reports on recent progress in the design of MXene nanosheets for drug delivery, antimicrobial activity, and biosensing. The researchers found that MXenes can be functionalized to support diagnostic imaging and therapeutic interventions. The paper also discusses the potential of MXenes to circulate within the vascular system, which may enhance their therapeutic efficacy. Biosafety issues were identified as a critical area requiring further investigation. The authors suggest that the unique physiochemical properties of MXenes may allow them to meet the strict requirements of biomedicine. The study proposes that engineered MXenes could become attractive platforms for multiple biomedical applications. These findings may contribute to the development of new nanomedicine strategies.

The authors synthesize the evidence to suggest that 2D MXenes may offer a novel platform for biomedical applications due to their unique physiochemical properties. They propose that MXenes could be engineered to support therapeutic and diagnostic functions. The study highlights the need for further research on biosafety and clinical translation of MXene-based nanosystems. The researchers suggest that the metallic conductivity and hydrophilic nature of MXenes may enable their use in vascular-related applications. The paper concludes that MXenes could become one of the most attractive biocompatible nanoplatforms for biomedical use. The authors emphasize the importance of addressing biosafety concerns before clinical adoption. They propose that the recent progress in MXene design and synthesis may lead to new paradigms in nanomedicine. These findings may inform future research directions in biomedical nanomaterials.